Recombinant Human GPR21 Protein，GST

GPR21, or G protein-coupled receptor 21, is a member of the GPR family of receptors and is predominantly expressed in the brain, particularly in regions associated with energy metabolism and appetite regulation. Its physiological roles have gained interest due to its potential implications in metabolic disorders, obesity, and neurodegenerative diseases. Understanding GPR21's signaling pathways and functions could provide insights into its role in the central nervous system and its interaction with various ligands. The recombinant GPR21 protein is used extensively in research to elucidate its structure-function relationships, investigate its ligand binding properties, and explore its downstream signaling mechanisms. Moreover, the generation of recombinant GPR21 allows for high-throughput screening of potential therapeutic compounds, contributing to the development of novel drugs targeted at modulating its activity for the treatment of metabolic diseases. By harnessing advanced techniques such as protein crystallization and molecular modeling, researchers aim to decipher the intricate dynamics of GPR21 and its relevance in maintaining energy homeostasis and neuronal health. The ongoing studies of GPR21 not only enhance our understanding of basic biochemistry but also hold promise for identifying new strategies in combating obesity, diabetes, and related health issues. Consequently, the recombinant expression and characterization of GPR21 remain pivotal in translating basic research into therapeutic applications, making it a valuable target for pharmaceutical development in the realm of metabolic health.